Prof. Dr. Nathan Subramaniam is Honorary Professor and Professor at the Faculty of Medicine and Biochemical Sciences at the University of Queensland and head of the Research Group on Liver Diseases and Iron Disorders at the Institute of Health and Biomedical Innovation (IHBI) since August 2016. PhD from Purdue University, W. Lafayette, Indiana, USA, 1990. Performed postdoctoral research stays at the University of California at Davis, USA and in Singapore. In 1999 he set up his own research group, the Membrane Transport Laboratory at the Queensland Medical Research Institute, Brisbane, Australia. His group is expert in hereditary hemochromatosis and in studies of liver injury and hepatic regulation of iron homeostasis. He has also developed new mass sequencing tools to examine the molecular basis of iron metabolism disorders, as well as, new in vitro and in vivo models to investigate hepatic damage and iron metabolism.        

 His group is expert in hereditary hemochromatosis and in studies of liver injury and hepatic regulation of iron homeostasis. He has also developed new mass sequencing tools to examine the molecular basis of iron metabolism disorders, as well as, new in vitro and in vivo models to investigate hepatic damage and iron metabolism.